You have successfully logged out.
Introcan Safety® Family of Passive Safety IV Catheters
Vascular access is an indispensable element of patient care, with over 70% of hospitalized patients requiring peripheral intravenous catheters (PIVCs).1 Even though it's a routine procedure, the placement of PIVCs remains a complex process with risks and complications for both patients and clinicians.
0
On average, healthcare workers sustain 31 sharps injuries per 100 occupied beds per year,2 resulting in possible transmissions of HIV, HBV and HCV.3
0%
Over 3% of sharps injuries were caused by PIVCs.2
$ 0
Annual costs to the U.S. healthcare system are estimated at $3,042 per victim to treat a needlestick injury,4 in addition to an immeasurable emotional toll.4
At B. Braun, we are committed to the critical processes and products needed to help you address this serious issue and prevent many of the complications associated with peripheral IV therapy. That’s why our technologies and solutions, like the Peripheral Advantage® Program, are designed to facilitate the best possible outcomes around vascular access care.
Needlestick injuries continue to be a serious risk faced by clinicians in their daily routines, potentially exposing them to bloodborne pathogens.3 Our IV catheters are designed to make access easy while preventing accidental needlestick injuries and reducing the risk of bloodborne pathogen exposure.
Introcan Safety IV Catheters are designed to provide safe and efficient IV access
Safety happens automatically thanks to the Introcan Safety Family of IV Catheters with passive safety, which helps your health system:
Fully automatic passive safety devices are proven to prevent needlestick injuries 2x better than a semi-automatic “push button” safety shield and 3x better than a manually sliding shield6
The use of blood control IV catheters helps reduce a clinician’s risk to blood exposure from spillage, and helps reduce the need for additional cleanup time and materials. As the leader in PIVCs, with the Introcan Safety family, we offer a portfolio of blood control passive safety catheters to meet your clinical needs.7
Our Introcan Safety Family of IV Catheters offers a full line of gauge sizes and configurations, including blood control, all with fully automatic passive safety
The Introcan Safety Deep Access Longer Length Peripheral Catheters help reduce the risk of catheter failure and complications associated with accessing deeper veins.9
The Introcan Safety Deep Access IV Catheter has been proven to lengthen PIVC dwell times to approximately 5.7 days vs. 3.9 days9
One portfolio offers a broad range of gauges, lengths and catheter materials for various therapy needs. It is designed to make the transition easier from one product to the next, help minimize training and expedite delivery of care.
Smaller, lighter components help your facility cut disposal costs and go easier on the environment by generating less waste10
Vascular Access
1Cooke M., et al, (2018). Not "just" an IV line: Consumer perspective on PIVC, PLoS ONE 13(2), 1-18.
2International Safety Center. U.S. EPINet Sharps Injury and Blood and Body Fluid Exposure Surveillance Research Group.2021 Sharp Object Injury Report. Accessed October 18, 2023. https://internationalsafetycenter.org/exposure-reports/
3Centers for Disease Control and Prevention. Sharps Safety for Healthcare Settings. Available at https://www.cdc.gov/sharpssafety. Last accessed November 3, 2020.
4 Needlestick injuries cost U.S. healthcare system more than $1 billion a year. Medical Laboratory Observer. August 29, 2013. Accessed October 18, 2023. https://www.mlo-online.com/home/article/13005629/needlestick-injuries-cost-ushealthcare-system-more-than-1-billion-a-year
5Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice. J Infus Nurs. 2021; 44(suppl 1):S1-S224. doi: 10.1097/NAN.0000000000000396.
6Tosini W, Ciotti C, Goyer F, Lolom I, L'Heriteau F, Abiteboul D, et al. Needlestick Injury Rates According to Different Types of Safety-Engineered Devices: Results of a French Multicenter Study. Infection Control Hosp Epidemiol. 2010 Apr;31(4):402-7.
7Richardson D, “Reducing blood exposure risks and costs associated with SPIVC insertion”, Nursing Management, vol. 42, no. 12, Dec 2011 (reprint p. 1-4).
8Haeseler G. Hildebrand M. Fritscher J. Efficacy and base of use of an intravenous catheter designed to prevent blood leakage: a prospective observational trial. 2015. J Vasc Access: 1-4.
9Bahl A, Hijazi, M., Chen, Nai-Wei, Lachapelle-Clavette, L., & Price, J. (2020). Ultralong versus standard long peripheral intravenous catheters: A randomized controlled trial of ultrasonographically guided catheter survival. Annals of Emergency Medicine, 76(2), 134-142. https://doi.org/10.106/j.annemergmed.2019.11.013
10B. Braun Data on File.